Chatham Lodging Trust Faces Significant Q3 Headwinds

Chatham Lodging Trust, a real estate investment trust specializing in hotel properties, reported disappointing financial results for the third quarter of 2025. The company fell short of market expectations on multiple fronts, with both earnings per share and revenue missing analyst projections. Management’s guidance for the current quarter suggests these challenges are likely to persist.

Key Performance Metrics Disappoint

The hotel REIT announced earnings of $0.03 per share, coming in below the anticipated $0.04 per share. Revenue generation also proved disappointing, reaching $78.41 million against expectations of $79.68 million. Particularly concerning was the 2.5% decline in Revenue Per Available Room (RevPAR), a crucial industry performance indicator.

Management attributed the weak performance to challenging conditions in several key markets, with Austin, Dallas, and San Diego specifically mentioned as underperforming locations. The outlook remains cautious, with company leadership projecting an additional RevPAR decrease between 2.5% and 3.5% for the fourth quarter.

Strategic Moves Amid Market Pressure

Despite the disappointing quarterly figures, Chatham Lodging’s management team has been actively implementing strategic initiatives. The company completed the sale of five hotel properties during the quarter, with another currently listed for disposal. These asset sales form part of a broader strategy that includes maintaining conservative debt levels and continuing share repurchase programs.

Should investors sell immediately? Or is it worth buying Chatham Lodging?

The market response to the earnings release was negative, with shares declining 0.78% to settle at $6.35. Dennis Craven, the company’s Chief Operating Officer, characterized 2025 as a “crazy year” for the hotel sector, offering a frank assessment of current market dynamics.

Divergence Between Analyst Views and Operational Reality

Current analyst coverage presents a more optimistic picture than recent operational performance might suggest. Two market researchers maintain buy recommendations on the equity, with an average price target of $8.00 representing nearly 18% potential upside from current levels. Technical analysis indicators further support this positive sentiment, signaling a “Strong Buy” recommendation.

The critical question remains whether operational performance can align with this analytical optimism. Investors will be watching closely for the next quarterly report scheduled for March 2026, which should indicate whether management’s strategic initiatives are effectively addressing the persistent RevPAR challenges or if these issues will continue to pressure the share price.